Stock Events

Stock Events

Xenetic Biosciences 

$3.53
27
-$0.03-0.84% Friday 20:00

Statistics

Day High
3.61
Day Low
3.3
52W High
10.36
52W Low
2.02
Volume
45,200
Avg. Volume
-
Mkt Cap
8.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.72
-0.53
-0.33
-0.14
Expected EPS
N/A
Actual EPS
N/A

Financials

-158.4%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
5MRevenue
-7.92MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XBIO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.92B
CRISPR Therapeutics is involved in gene editing, a field that overlaps with Xenetic's work on drug delivery and biosciences, making them direct competitors in the biotech innovation space.
Editas Medicine
EDIT
Mkt Cap287.74M
Editas Medicine operates in the genome editing sector, directly competing with Xenetic Biosciences in the development of gene therapies.
Intellia Therapeutics
NTLA
Mkt Cap1.59B
Intellia Therapeutics is a leading company in CRISPR/Cas9 technology for genome editing, competing in the same biotech and gene therapy space as Xenetic.
Sangamo Therapeutics
SGMO
Mkt Cap104.07M
Sangamo Therapeutics focuses on genomic medicine, including gene editing and therapy, positioning it as a competitor in the same innovative biotech field as Xenetic.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.49B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, potentially competing with Xenetic in the rare disease market.
Alnylam Pharmaceuticals
ALNY
Mkt Cap42.72B
Alnylam Pharmaceuticals is a leader in RNAi (RNA interference) therapeutics, competing in the broader biotech space for novel drug delivery systems like Xenetic.
Beam Therapeutics
BEAM
Mkt Cap2.79B
Beam Therapeutics specializes in precision genetic medicines through base editing, a form of gene editing competing with Xenetic's bioscience approaches.
Voyager Therapeutics
VYGR
Mkt Cap222.9M
Voyager Therapeutics focuses on the development of gene therapies for neurodegenerative diseases, potentially competing with Xenetic in gene therapy delivery technologies.

About

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Show more...
CEO
Mr. James F. Parslow
Employees
2
Country
United States
ISIN
US9840156023

Listings

MU
DE
3XB0.MU
STU
DE
3XB0.STU
BOATS
BOATS
XBIO.BOATS
XNAS
US
XBIO

0 Comments

Share your thoughts

FAQ

What is Xenetic Biosciences stock price today?▼
The current price of XBIO is $3.53 USD — it has decreased by -0.84% in the past 24 hours. Watch Xenetic Biosciences stock price performance more closely on the chart.
What is Xenetic Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Xenetic Biosciences stocks are traded under the ticker XBIO.
Is Xenetic Biosciences stock price growing?▼
XBIO stock has risen by +15.36% compared to the previous week, the month change is a +16.5% rise, over the last year Xenetic Biosciences has showed a +45.21% increase.
What is Xenetic Biosciences market cap?▼
Today Xenetic Biosciences has the market capitalization of 8.09M
When is the next Xenetic Biosciences earnings date?▼
Xenetic Biosciences is going to release the next earnings report on May 07, 2026.
What is Xenetic Biosciences revenue for the last year?▼
Xenetic Biosciences revenue for the last year amounts to 5M USD.
What is Xenetic Biosciences net income for the last year?▼
XBIO net income for the last year is -7.92M USD.
How many employees does Xenetic Biosciences have?▼
As of April 19, 2026, the company has 2 employees.
In which sector is Xenetic Biosciences located?▼
Xenetic Biosciences operates in the Health & Wellness sector.
When did Xenetic Biosciences complete a stock split?▼
The last stock split for Xenetic Biosciences was on May 15, 2023 with a ratio of 1:10.
Where is Xenetic Biosciences headquartered?▼
Xenetic Biosciences is headquartered in Framingham, United States.